Table I.
Baseline Demographics and Clinical Characteristics of Patients.
| All Patients (N= 465) | No Statin (n=182) | Statin (n= 283) | P Value | |
|---|---|---|---|---|
| Age, years, mean (SE) | 67 (0.3) | 65 (0.6) | 68 (0.4) | 0.0004 |
| BMI, median (IQI) | 28.0 (24.7, 31.9) | 26.8 (24.3, 30.3) | 28.8 (25.1, 33.0) | 0.0006 |
| Male, n (%) | 453 (97.2) | 173 (95.0) | 280 (98.9) | 0.01 |
| Caucasian, n (%) | 435 (93.3) | 159 (87.3) | 276 (97.5) | <0.0001 |
| African American, n (%) | 22 (4.7) | 17 (9.3) | 5 (1.76) | <0.0001 |
| Diabetes Mellitus, n (%) | 131 (28.1) | 26 (14.2) | 105 (37.1) | <0.0001 |
| Hypertension, n (%) | 281 (60.3) | 91 (50.0) | 190 (67.1) | <0.0001 |
| Hyperlipidemia, n (%) | 334 (71.6) | 77 (42.3) | 257 (90.8) | <0.0001 |
| Total Cholesterol, mean (SE) | 177.6 (2.0) | 187.6 (3.2) | 171.1 (2.5) | 0.0001 |
| HDL Cholesterol, median (IQI) | 42 (26, 50) | 43 (37, 55) | 41 (36, 48) | 0.0071 |
| Statin Use, n (%) | 283 (60.8) | --- | --- | --- |
| Current Smoker, n (%) | 221 (47.4) | 95 (52.1) | 126 (44.5) | 0.106 |
| Family History of Early CAD, n (%) | 33 (7.0) | 14 (7.6) | 19 (6.7) | 0.688 |
| CAD, n (%) | 83 (17.8) | 14 (7.6) | 69 (24.3) | <0.0001 |
| Prior MI, n (%) | 24 (5.1) | 4 (2.1) | 20 (7.0) | 0.021 |
| Prior CABG, n (%) | 25 (5.3) | 2 (1.0) | 23 (8.1) | 0.001 |
| ASCVD Risk Score, mean (SE) | 21.6 (0.6) | 18.4 (0.8) | 23.7 (0.8) | <0.0001 |
| CACS, median (IQI) | 595 (125, 1570) | 307 (54, 814) | 941 (276, 2104) | <0.0001 |
BMI = body mass index; CAD = coronary artery disease; MI = myocardial infarction; CABG = coronary artery bypass graft surgery; ASCVD = atherosclerotic cardiovascular disease; CACS = coronary artery calcium score.